How it works
With a network of journalists and analysts crisscrossing the globe, we track product progress from submission to approval. We also draw on the strength and expertise of the rest of the pharma intelligence family of analytical and market intelligence tools.
Analysis covers key topic areas such as:
- drug approval standards and expedited review programs
- clinical trial design
- drug safety
- legislation
- legal and IP
- US FDA advisory committees, Europe’s CHMP
- drug approvals
- market access and reimbursement
- manufacturing
- marketing
- cross-regional trends
